カテゴリー： QYResearch, 世界

HPV関連障害の世界市場：規模・現状・予測2019-2025

【英語タイトル】Global HPV Associated Disorder Market Size, Status and Forecast 2019-2025

QYResearchが出版した調査資料（DATA909X18552）・商品コード：DATA909X18552
・発行会社（調査会社）：QYResearch
・発行日：2019年11月25日（※2024年版があります。お問い合わせください）
・ページ数：93
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,900 ⇒換算￥577,200見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,850 ⇒換算￥865,800見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,800 ⇒換算￥1,154,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※当調査レポートでは、HPV関連障害の世界市場について調査・分析し、HPV関連障害の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（予防、治療）、用途別（病院薬局、小売薬局、オンライン薬局）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。


・レポートの概要
・世界のHPV関連障害市場動向
・主要企業別マーケットシェア
・HPV関連障害の種類別市場規模2014-2019
（予防、治療）
・HPV関連障害の用途別市場規模2014-2019
（病院薬局、小売薬局、オンライン薬局）
・HPV関連障害の北米市場：主要企業・種類別/用途別市場規模
・HPV関連障害のヨーロッパ市場：主要企業・種類別/用途別市場規模
・HPV関連障害の中国市場：主要企業・種類別/用途別市場規模
・HPV関連障害の日本国内市場：主要企業・種類別/用途別市場規模
・HPV関連障害の東南アジア市場：主要企業・種類別/用途別市場規模
・HPV関連障害のインド市場：主要企業・種類別/用途別市場規模
・HPV関連障害の中南米市場：主要企業・種類別/用途別市場規模
・主要企業のプロフィール
（Merck & Co., Inc、GlaxoSmithKline plc、F. Hoffmann-La Roche Ltd、Pfizer, Inc.、Allergan plc、AstraZeneca plc、Biocon Ltd、Eli Lilly and Company）
・HPV関連障害の市場規模予測2019-2025
（種類別、用途別、地域別市場予測）
・アナリストの観点・結論
...
【レポートの概要】

HPV Associated Disorder means a series of diseases associated with HPV, either pre-disease or some of the diseases induced thereby.In 2018, the global HPV Associated Disorder market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global HPV Associated Disorder status, future forecast, growth opportunity, key market and key players. The study objectives are to present the HPV Associated Disorder development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Merck & Co., Inc
GlaxoSmithKline plc
F. Hoffmann-La Roche Ltd
Pfizer, Inc.
Allergan plc
AstraZeneca plc
Biocon Ltd
Eli Lilly and Company

Market segment by Type, the product can be split into
Prevention
Treatment

Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global HPV Associated Disorder status, future forecast, growth opportunity, key market and key players.
To present the HPV Associated Disorder development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of HPV Associated Disorder are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global HPV Associated Disorder Market Size Growth Rate by Type (2014-2025)
1.4.2 Prevention
1.4.3 Treatment
1.5 Market by Application
1.5.1 Global HPV Associated Disorder Market Share by Application (2019-2025)
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 HPV Associated Disorder Market Size
2.2 HPV Associated Disorder Growth Trends by Regions
2.2.1 HPV Associated Disorder Market Size by Regions (2019-2025)
2.2.2 HPV Associated Disorder Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 HPV Associated Disorder Market Size by by Players
3.1.1 Global HPV Associated Disorder Revenue by by Players (2014-2019)
3.1.2 Global HPV Associated Disorder Revenue Market Share by by Players (2014-2019)
3.1.3 Global HPV Associated Disorder Market Concentration Ratio (CR5 and HHI)
3.2 HPV Associated Disorder Key Players Head office and Area Served
3.3 Key Players HPV Associated Disorder Product/Solution/Service
3.4 Date of Enter into HPV Associated Disorder Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global HPV Associated Disorder Market Size by Type (2014-2019)
4.2 Global HPV Associated Disorder Market Size by Application (2014-2019)

5 North America
5.1 North America HPV Associated Disorder Market Size (2014-2019)
5.2 HPV Associated Disorder Key Players in North America
5.3 North America HPV Associated Disorder Market Size by Type
5.4 North America HPV Associated Disorder Market Size by Application

6 Europe
6.1 Europe HPV Associated Disorder Market Size (2014-2019)
6.2 HPV Associated Disorder Key Players in Europe
6.3 Europe HPV Associated Disorder Market Size by Type
6.4 Europe HPV Associated Disorder Market Size by Application

7 China
7.1 China HPV Associated Disorder Market Size (2014-2019)
7.2 HPV Associated Disorder Key Players in China
7.3 China HPV Associated Disorder Market Size by Type
7.4 China HPV Associated Disorder Market Size by Application

8 Japan
8.1 Japan HPV Associated Disorder Market Size (2014-2019)
8.2 HPV Associated Disorder Key Players in Japan
8.3 Japan HPV Associated Disorder Market Size by Type
8.4 Japan HPV Associated Disorder Market Size by Application

9 Southeast Asia
9.1 Southeast Asia HPV Associated Disorder Market Size (2014-2019)
9.2 HPV Associated Disorder Key Players in Southeast Asia
9.3 Southeast Asia HPV Associated Disorder Market Size by Type
9.4 Southeast Asia HPV Associated Disorder Market Size by Application

10 India
10.1 India HPV Associated Disorder Market Size (2014-2019)
10.2 HPV Associated Disorder Key Players in India
10.3 India HPV Associated Disorder Market Size by Type
10.4 India HPV Associated Disorder Market Size by Application

11 Central & South America
11.1 Central & South America HPV Associated Disorder Market Size (2014-2019)
11.2 HPV Associated Disorder Key Players in Central & South America
11.3 Central & South America HPV Associated Disorder Market Size by Type
11.4 Central & South America HPV Associated Disorder Market Size by Application

12 International Players Profiles
12.1 Merck & Co., Inc
12.1.1 Merck & Co., Inc Company Details
12.1.2 Company Description and Business Overview
12.1.3 HPV Associated Disorder Introduction
12.1.4 Merck & Co., Inc Revenue in HPV Associated Disorder Business (2014-2019))
12.1.5 Merck & Co., Inc Recent Development
12.2 GlaxoSmithKline plc
12.2.1 GlaxoSmithKline plc Company Details
12.2.2 Company Description and Business Overview
12.2.3 HPV Associated Disorder Introduction
12.2.4 GlaxoSmithKline plc Revenue in HPV Associated Disorder Business (2014-2019)
12.2.5 GlaxoSmithKline plc Recent Development
12.3 F. Hoffmann-La Roche Ltd
12.3.1 F. Hoffmann-La Roche Ltd Company Details
12.3.2 Company Description and Business Overview
12.3.3 HPV Associated Disorder Introduction
12.3.4 F. Hoffmann-La Roche Ltd Revenue in HPV Associated Disorder Business (2014-2019)
12.3.5 F. Hoffmann-La Roche Ltd Recent Development
12.4 Pfizer, Inc.
12.4.1 Pfizer, Inc. Company Details
12.4.2 Company Description and Business Overview
12.4.3 HPV Associated Disorder Introduction
12.4.4 Pfizer, Inc. Revenue in HPV Associated Disorder Business (2014-2019)
12.4.5 Pfizer, Inc. Recent Development
12.5 Allergan plc
12.5.1 Allergan plc Company Details
12.5.2 Company Description and Business Overview
12.5.3 HPV Associated Disorder Introduction
12.5.4 Allergan plc Revenue in HPV Associated Disorder Business (2014-2019)
12.5.5 Allergan plc Recent Development
12.6 AstraZeneca plc
12.6.1 AstraZeneca plc Company Details
12.6.2 Company Description and Business Overview
12.6.3 HPV Associated Disorder Introduction
12.6.4 AstraZeneca plc Revenue in HPV Associated Disorder Business (2014-2019)
12.6.5 AstraZeneca plc Recent Development
12.7 Biocon Ltd
12.7.1 Biocon Ltd Company Details
12.7.2 Company Description and Business Overview
12.7.3 HPV Associated Disorder Introduction
12.7.4 Biocon Ltd Revenue in HPV Associated Disorder Business (2014-2019)
12.7.5 Biocon Ltd Recent Development
12.8 Eli Lilly and Company
12.8.1 Eli Lilly and Company Company Details
12.8.2 Company Description and Business Overview
12.8.3 HPV Associated Disorder Introduction
12.8.4 Eli Lilly and Company Revenue in HPV Associated Disorder Business (2014-2019)
12.8.5 Eli Lilly and Company Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table HPV Associated Disorder Key Market Segments
Table Key Players HPV Associated Disorder Covered
Table Global HPV Associated Disorder Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Prevention Figures
Table Key Players of Prevention
Figuer Treatment Figures
Table Key Players of Treatment
Table Global HPV Associated Disorder Market Size Growth by Application 2019-2025 (Million US$)
Figure Global HPV Associated Disorder Market Share by Application in 2018 & 2025
Figure Hospital Pharmacies Case Studies
Figure Retail Pharmacies Case Studies
Figure Online Pharmacies Case Studies
Figure HPV Associated Disorder Report Years Considered
Figure Global HPV Associated Disorder Market Size and Growth Rate 2014-2025 (Million US$)
Table Global HPV Associated Disorder Market Size by Regions 2019-2025 (Million US$)
Table Global HPV Associated Disorder Market Size by Regions 2019-2025 (Million US$)
Table Global HPV Associated Disorder Market Share by Regions 2014-2019
Figure Global HPV Associated Disorder Market Share by Regions 2014-2019
Figure Global HPV Associated Disorder Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global HPV Associated Disorder Revenue by by Players (2014-2019) (Million US$)
Table Global HPV Associated Disorder Market Share by by Players (2014-2019)
Figure Global HPV Associated Disorder Market Share by by Players in 2018
Table Global HPV Associated Disorder by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players HPV Associated Disorder Product/Solution/Service
Table Date of Enter into HPV Associated Disorder Market
Table Mergers & Acquisitions, Expansion Plans
Table Global HPV Associated Disorder Market Size by Type (2014-2019) (Million US$)
Table Global HPV Associated Disorder Market Size Share by Type (2014-2019)
Figure Global HPV Associated Disorder Market Size Market Share by Type (2014-2019)
Table Global HPV Associated Disorder Market Size by Application (2014-2019) (Million US$)
Table Global HPV Associated Disorder Market Size Share by Application (2014-2019)
Figure Global HPV Associated Disorder Market Size Market Share by Application (2014-2019)
Figure Global HPV Associated Disorder Revenue Market Share by Application in 2018
Figure North America HPV Associated Disorder Market Size 2014-2019 (Million US$)
Table North America Key Players HPV Associated Disorder Revenue (2018-2019) (Million US$)
Table North America Key Players HPV Associated Disorder Market Share (2018-2019)
Table North America HPV Associated Disorder Market Size by Type 2014-2019 (Million US$)
Table North America HPV Associated Disorder Market Share by Type 2014-2019
Table North America HPV Associated Disorder Market Size by Application 2014-2019 (Million US$)
Table North America HPV Associated Disorder Market Share by Application 2014-2019
Figure Europe HPV Associated Disorder Market Size 2014-2019 (Million US$)
Table Europe Key Players HPV Associated Disorder Revenue (2018-2019) (Million US$)
Table Europe Key Players HPV Associated Disorder Market Share (2018-2019)
Table Europe HPV Associated Disorder Market Size by Type 2014-2019 (Million US$)
Table Europe HPV Associated Disorder Market Share by Type 2014-2019
Table Europe HPV Associated Disorder Market Size by Application 2014-2019 (Million US$)
Table Europe HPV Associated Disorder Market Share by Application 2014-2019
Figure China HPV Associated Disorder Market Size 2014-2019 (Million US$)
Table China Key Players HPV Associated Disorder Revenue (2018-2019) (Million US$)
Table China Key Players HPV Associated Disorder Market Share (2018-2019)
Table China HPV Associated Disorder Market Size by Type 2014-2019 (Million US$)
Table China HPV Associated Disorder Market Share by Type 2014-2019
Table China HPV Associated Disorder Market Size by Application 2014-2019 (Million US$)
Table China HPV Associated Disorder Market Share by Application 2014-2019
Figure Japan HPV Associated Disorder Market Size 2014-2019 (Million US$)
Table Japan Key Players HPV Associated Disorder Revenue (2018-2019) (Million US$)
Table Japan Key Players HPV Associated Disorder Market Share (2018-2019)
Table Japan HPV Associated Disorder Market Size by Type 2014-2019 (Million US$)
Table Japan HPV Associated Disorder Market Share by Type 2014-2019
Table Japan HPV Associated Disorder Market Size by Application 2014-2019 (Million US$)
Table Japan HPV Associated Disorder Market Share by Application 2014-2019
Figure Southeast Asia HPV Associated Disorder Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players HPV Associated Disorder Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players HPV Associated Disorder Market Share (2018-2019)
Table Southeast Asia HPV Associated Disorder Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia HPV Associated Disorder Market Share by Type 2014-2019
Table Southeast Asia HPV Associated Disorder Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia HPV Associated Disorder Market Share by Application 2014-2019
Figure India HPV Associated Disorder Market Size 2014-2019 (Million US$)
Table India Key Players HPV Associated Disorder Revenue (2018-2019) (Million US$)
Table India Key Players HPV Associated Disorder Market Share (2018-2019)
Table India HPV Associated Disorder Market Size by Type 2014-2019 (Million US$)
Table India HPV Associated Disorder Market Share by Type 2014-2019
Table India HPV Associated Disorder Market Size by Application 2014-2019 (Million US$)
Table India HPV Associated Disorder Market Share by Application 2014-2019
Figure Central & South America HPV Associated Disorder Market Size 2014-2019 (Million US$)
Table Central & South America Key Players HPV Associated Disorder Revenue (2018-2019) (Million US$)
Table Central & South America Key Players HPV Associated Disorder Market Share (2018-2019)
Table Central & South America HPV Associated Disorder Market Size by Type 2014-2019 (Million US$)
Table Central & South America HPV Associated Disorder Market Share by Type 2014-2019
Table Central & South America HPV Associated Disorder Market Size by Application 2014-2019 (Million US$)
Table Central & South America HPV Associated Disorder Market Share by Application 2014-2019
Table Merck & Co., Inc Company Details
Table Merck & Co., Inc Revenue in HPV Associated Disorder Business 2014-2019 (Million US$)
Figure Merck & Co., Inc Revenue Growth Rate in HPV Associated Disorder Business (2014-2019)
Table Merck & Co., Inc Recent Development
Table GlaxoSmithKline plc Company Details
Table GlaxoSmithKline plc Revenue in HPV Associated Disorder Business 2014-2019 (Million US$)
Figure GlaxoSmithKline plc Revenue Growth Rate in HPV Associated Disorder Business (2014-2019)
Table GlaxoSmithKline plc Recent Development
Table F. Hoffmann-La Roche Ltd Company Details
Table F. Hoffmann-La Roche Ltd Revenue in HPV Associated Disorder Business 2014-2019 (Million US$)
Figure F. Hoffmann-La Roche Ltd Revenue Growth Rate in HPV Associated Disorder Business (2014-2019)
Table F. Hoffmann-La Roche Ltd Recent Development
Table Pfizer, Inc. Company Details
Table Pfizer, Inc. Revenue in HPV Associated Disorder Business 2014-2019 (Million US$)
Figure Pfizer, Inc. Revenue Growth Rate in HPV Associated Disorder Business (2014-2019)
Table Pfizer, Inc. Recent Development
Table Allergan plc Company Details
Table Allergan plc Revenue in HPV Associated Disorder Business 2014-2019 (Million US$)
Figure Allergan plc Revenue Growth Rate in HPV Associated Disorder Business (2014-2019)
Table Allergan plc Recent Development
Table AstraZeneca plc Company Details
Table AstraZeneca plc Revenue in HPV Associated Disorder Business 2014-2019 (Million US$)
Figure AstraZeneca plc Revenue Growth Rate in HPV Associated Disorder Business (2014-2019)
Table AstraZeneca plc Recent Development
Table Biocon Ltd Company Details
Table Biocon Ltd Revenue in HPV Associated Disorder Business 2014-2019 (Million US$)
Figure Biocon Ltd Revenue Growth Rate in HPV Associated Disorder Business (2014-2019)
Table Biocon Ltd Recent Development
Table Eli Lilly and Company Company Details
Table Eli Lilly and Company Revenue in HPV Associated Disorder Business 2014-2019 (Million US$)
Figure Eli Lilly and Company Revenue Growth Rate in HPV Associated Disorder Business (2014-2019)
Table Eli Lilly and Company Recent Development
Table Global HPV Associated Disorder Market Size by Regions (Million US$) 2019-2025
Figure Global HPV Associated Disorder Market Size Share by Regions (2019-2025)
Figure Global HPV Associated Disorder Market Size Share by Regions in 2025
Figure North America HPV Associated Disorder Market Size Forecast (2019-2025)(Million USD)
Figure Europe HPV Associated Disorder Market Size Forecast (2019-2025)(Million USD)
Figure China HPV Associated Disorder Market Size Forecast (2019-2025)(Million USD)
Figure Japan HPV Associated Disorder Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia HPV Associated Disorder Market Size Forecast (2019-2025)(Million USD)
Figure India HPV Associated Disorder Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America HPV Associated Disorder Market Size Forecast (2019-2025)(Million USD)
Table Global HPV Associated Disorder Market Size by Product (2019-2025) (Million US$)
Figure Global HPV Associated Disorder Market Size by Product (2019-2025)
Figure Global HPV Associated Disorder Market Size by Product in 2025
Table Global HPV Associated Disorder Market Size by Application (2019-2025) (Million US$)
Figure Global HPV Associated Disorder Market Size by Application (2019-2025)
Figure Global HPV Associated Disorder Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Merck & Co., Inc、GlaxoSmithKline plc、F. Hoffmann-La Roche Ltd、Pfizer, Inc.、Allergan plc、AstraZeneca plc、Biocon Ltd、Eli Lilly and Company

★調査レポート[HPV関連障害の世界市場：規模・現状・予測2019-2025] (コード：DATA909X18552)販売に関する免責事項を必ずご確認ください。
★調査レポート[HPV関連障害の世界市場：規模・現状・予測2019-2025]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 神経疾患診断の世界市場：規模・現状・予測2019-2025
    DATA909X18750 / QYResearch / 2019年11月25日 / ※当調査レポートでは、神経疾患診断の世界市場について調査・分析し、神経疾患診断の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（イメージング技術、体外診断技術）、用途別（病院およびクリニック、診断センター、外来診療センター）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の神経疾患診断市場動向 ・主要企業別マーケットシェア ・神経疾患診断の種類別市場規模2014-2019 （イメージング技術、体外診断技術） ・神経疾患診断の用途別市場規模2014-2019 （病院およびクリニック、診断センター、外来診療センター） ・神経疾患診断の北米市場：主要企業・種類別/用途別市場規模 ・神経疾患診断のヨーロッパ市場：主要企業・種類別/用途別市場規模...Neurological disorders diagnostic tools are tools used to diagnose various neurological disorders.In 2018, the global Neurological Disorder Diagnostics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Neurological Disorder Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Neurological Disorder Diagnostics development in North America, Europe and Asia-Pacific. The key players covered in this study Siemens Philips GE Esaote Masimo Croton Healthcare Neusoft ... Market segment by...
  • 強迫性障害治療薬の世界市場：規模・現状・予測2019-2025
    DATA909X18761 / QYResearch / 2019年11月25日 / ※当調査レポートでは、強迫性障害治療薬の世界市場について調査・分析し、強迫性障害治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（SSRI、TCA、その他）、用途別（病院、クリニック、研究所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の強迫性障害治療薬市場動向 ・主要企業別マーケットシェア ・強迫性障害治療薬の種類別市場規模2014-2019 （SSRI、TCA、その他） ・強迫性障害治療薬の用途別市場規模2014-2019 （病院、クリニック、研究所、その他） ・強迫性障害治療薬の北米市場：主要企業・種類別/用途別市場規模 ・強迫性障害治療薬のヨーロッパ市場：主要企業・種類別/用途別市場規模...Obsessive–compulsive disorder (OCD) is a mental disorder in which a person feels the need to perform certain routines repeatedly (called "compulsions"), or has certain thoughts repeatedly (called "obsessions").The launch of new molecules is one of the primary drivers for the obsessive-compulsive disorder drugs market growth. Conventional therapies used to treat the condition are only short-term treatment. The conventional anti-anxiety, antipsychotic, and antidepressant drugs are administered along with behavioral therapies and psychotherapy. The current long-term treatment involves the management of the condition, which requires patient compliance that has its drawbacks. Vendors are leveraging this situation and are focusing on the R&D...
  • 心的外傷後ストレス障害治療法の世界市場：規模・現状・予測2019-2025
    DATA909X18850 / QYResearch / 2019年11月25日 / ※当調査レポートでは、心的外傷後ストレス障害治療法の世界市場について調査・分析し、心的外傷後ストレス障害治療法の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（抗うつ薬、抗不安薬、その他）、用途別（病院、診療所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の心的外傷後ストレス障害治療法市場動向 ・主要企業別マーケットシェア ・心的外傷後ストレス障害治療法の種類別市場規模2014-2019 （抗うつ薬、抗不安薬、その他） ・心的外傷後ストレス障害治療法の用途別市場規模2014-2019 （病院、診療所、その他） ・心的外傷後ストレス障害治療法の北米市場：主要企業・種類別/用途別市場規模 ・心的外傷後ストレス障害治療法のヨーロッパ市場：主要企業・種類別/用途別市場規模...The main treatments for post-traumatic stress disorder (PTSD) are psychological therapies and medication.In 2018, the global Post-Traumatic Stress Disorder Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Post-Traumatic Stress Disorder Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Post-Traumatic Stress Disorder Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. The key players covered in this study Pfizer, Inc. GlaxoSmithKline plc...

    • ◆H&Iグローバルリサーチのお客様（例）◆